Amprion Newsroom
Recent media coverage and announcements.
Podcast
Life Sciences 360
How Amprion's Test is Changing ALS Dementia and Parkinson's Disease Diagnosis
September 24, 2024
Read MorePodcast
Life Science Success
Dr. Russ Lebovitz: Revolutionizing Brain Health with Early Detection
September 26, 2024
Read MoreNews Article
Los Angeles Times
Bioscience Firms in Southern California Focus on Innovation & Collaboration
May 18, 2025
Read MoreNews Article
Diagnostics World
Trendspotting: Predictions for Diagnostics World in 2025
January 7, 2025
Read MoreNews Article
Neurology Live
Feasibility and Scalability of Amprion's Assay for Synucleinopathy Diagnosis: Russ Lebovitz MD PhD
January 24, 2025
Read MoreNews Article
Medical Product Outsourcing
Getting to the Point of In-Vitro Diagnostics
April 29, 2025
Read MoreNews Article
Today's Clinical Lab
New Biomarkers for Better Neurodegenerative Disease Diagnostics and Treatments
November 14, 2025
Read MoreNews Article
Neurology Live
Revolutionizing Dementia Research With Synuclein Biomarker Tests
August 13, 2023
Read MoreNews Article
Washington Post
Parkinson's is often misdiagnosed. New tests may change that.
October 10, 2024
Read MoreNews Article
Precision Medicine Online
NIH Researchers to Use Amprion CSF Test in Dementia Biomarker Validation Study
August 24, 2023
Read MoreNews Article
Fierce Biotech
New test detects Parkinson's biomarker before movement symptoms start
4/18/2023
Read MoreNews Article
Everyday Health
Lab Test May Detect Parkinson's Disease Even Before Symptoms Appear
4/17/2023
Read MoreNews Article
Parkinson's News Today
FDA letter supports use of new alpha-synuclein assay in trials
9/9/2024
Read More
Get in the Know
Bring biological certainty to your diagnosis with Amprion's SAAmplify-ɑSYN test. Order your shipping kits today and help move your patient beyond a probable diagnosis.
